Mangoceuticals (MGRX) Total Liabilities (2022 - 2026)

Mangoceuticals has disclosed Total Liabilities across 5 years of filings, most recently posting $1.6 million for Q2 2026.

• In Q2 2026, Total Liabilities rose 3.0% year-over-year to $1.6 million; the TTM figure through Jun 2026 stood at $1.6 million (up 3.0% YoY), while the FY2025 annual figure was $890568.0, down 37.52% from the prior year.
• Total Liabilities came in at $1.6 million for Q2 2026 at Mangoceuticals, up from $974571.0 in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $1.6 million in Q2 2026 to a low of $240684.0 in Q3 2023.
• Average Total Liabilities over 5 years is $961053.0, with a median of $974571.0 recorded in 2026.
• Year-over-year, Total Liabilities jumped 483.15% in 2024 and sank 42.7% in 2025.
• Over 5 years, Total Liabilities stood at $389257.0 in 2022, then declined by 29.09% to $276039.0 in 2023, then jumped by 416.4% to $1.4 million in 2024, then sank by 37.52% to $890568.0 in 2025, then jumped by 85.16% to $1.6 million in 2026.
• Per Business Quant data, the three most recent Total Liabilities figures were $1.6 million in Q2 2026, $974571.0 in Q1 2026, and $890568.0 in Q4 2025.